🔎 Trials Near Me

Home › Diffuse Scleroderma › Kansas

Diffuse Scleroderma clinical trials in Kansas

5 studies for Diffuse Scleroderma are looking for participants at sites in Kansas.

Cities in Kansas

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

  • EncompaSSc site in Kansas City, KS, Kansas City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07287670

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • University of Kansas Medical Center, Kansas City
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104

Platform Clinical Study for Conquering Scleroderma

  • University of Kansas School of Medicine, Kansas City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • University of Kansas Medical Center, Kansas City
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Aug 17, 2026 · NCT06328777

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

  • Nkarta Investigational Site, Fairway
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Aug 7, 2026 · NCT06733935

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.